GSK To Address Multiple Myeloma With First-In-Class Blenrep In EU
Approval Conditional On Further Studies, Risk Management Plan
The European Commission’s approval of GlaxoSmithKline’s Blenrep is one of the first major fruits of a refocused pipeline and development strategy at the big pharma company.
